Pfizer cited its clinical trials and data gathered since the vaccine was authorized in the US in reporting its initial conclusion that the evidence doesn’t suggest a connection.
The US pharma firm is in the process of compiling responses to queries raised by Drugs Controller General of India on its vaccine data, says a Pfizer spokesperson.
BioNTech SE Chief Executive Officer said if the current shot fails to be adequately protective, they could tweak it by updating small bits of genetic information called messenger RNA.
Govt had sought additional data on the vaccine candidates of companies seeking emergency use authorisation. So far, just one company has submitted this information.
Chairman of the European Medicines Agency’s pandemic taskforce said the antibody response seen from the shot shouldn’t be compromised by the effects of mutations in the new strain.
The trials for the vaccine in India are being carried out by Serum Institute of India (SII) and the company has applied for its emergency authorisation use.
The European Union is pushing for speed after national leaders have struggled to explain to residents why they’re still waiting for shots already being rolled out in the US and UK.
A healthcare worker in Alaska with no history of allergies experienced flushing and shortness of breath 10 minutes after receiving a shot, the state health department said.
Trump wants to send a ‘parallel message’ that the vaccine is safe & front-line workers, long-term care residents should be first to receive it, White House press secretary said.
Two questions are pertinent: Why does the Trump administration keep making the same mistakes on the peace proposal? And what does a hurried peace plan mean on the ground?
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS